Adjuvant Holdings Co Ltd
TSE:4929
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Adjuvant Holdings Co Ltd
EPS (Diluted)
Adjuvant Holdings Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adjuvant Holdings Co Ltd
TSE:4929
|
EPS (Diluted)
-ÂĄ12
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shiseido Co Ltd
TSE:4911
|
EPS (Diluted)
ÂĄ46
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-3%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
EPS (Diluted)
ÂĄ135
|
CAGR 3-Years
23%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
EPS (Diluted)
ÂĄ45
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
Kao Corp
TSE:4452
|
EPS (Diluted)
ÂĄ119
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-3%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
EPS (Diluted)
ÂĄ238
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
See Also
What is Adjuvant Holdings Co Ltd's EPS (Diluted)?
EPS (Diluted)
-12.5
JPY
Based on the financial report for Mar 20, 2024, Adjuvant Holdings Co Ltd's EPS (Diluted) amounts to -12.5 JPY.